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Diffusion weighted imaging (DWI) is based on an analysis of diffusion of water molecules (the so-called Brownian motion) [1, 2] . On DWI, areas that are characterised by normal diffusion of water are iso-or hypointense. On DWI, restriction of diffusion is observed as hyperintense signal, whereas a corresponding signal attenuation is seen in apparent diffusion coefficient (ADC) maps. Moreover, ADC maps allow for a quantitative analysis of true values of diffusion coefficients [2] .
Differential diagnosis of disseminated brain lesions that are characterised by restricted diffusion includes primarily acute or hyperacute ischaemic infarcts, multiple bacterial abscesses, demyelinating lesions in multiple sclerosis 
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patients, and various forms of primary central nervous lymphomas (PCNSL) [1] [2] [3] . In general, cerebral metastases do not display restricted diffusion or the decline in signal on ADC maps [4] ; in contrast, cerebral metastases could display increased diffusion with preserved or increased signal on ADC maps, if they are cystic or necrotic [1, 2, 5] . However, cases of cerebral metastases that were characterised by DWI hyperintensities with corresponding ADC hypointensities have been described [5, 6] . Because such radiological features suggest disseminated ischemic infarcts, they constitute an important clinical issue. Cases of cerebral metastases with restriction of diffusion described to date occurred in patients with lung cancer, breast cancer, colon cancer, testicular cancer, and renal cancer [6] [7] [8] . Therefore, cerebral metastases should be included in the differential diagnosis of disseminated cerebral lesions that display restricted diffusion on DWI, especially in patients with a history of cancer.
We describe a patient with small-cell lung cancer who had disseminated cerebral lesions that were characterised by DWI hyperintensities and lack of the contrast enhancement. Based on conventional MRI with DWI sequence, these lesions were initially diagnosed as disseminated ischaemic lesions, and later turned out to be cerebral metastases.
Case Report
A 53-year-old man, with a history of hypertension and small-cell cancer of the right lung (pathologically anaplastic microcellular carcinoma) that was diagnosed 2 months earlier and treated palliatively with etoposide and cisplatin, was admitted because of a clonic seizure in the right extremities that occurred one day before.
On admission, the following neurological signs were present: slight facial asymmetry to the right, slight weakness of the right upper extremity, and slight ataxia on finger-tonose testing; all signs were present throughout hospitalisation. Moreover, we observed clonic seizures of the right extremities that were successfully treated with intravenous clonazepam.
On contrast-enhanced haed computed tomography (CT) that was performed in the day of admission, we observed hyperdense foci in the frontal and parietal cortex on the left that did not enhance after contrast administration. They were interpreted as calcifications or haemorrhagic strokes ( Figure 1 ). On brain MRI that was performed two days later, there were small, disseminated, T2 and FLAIR hyperintensities in the bilateral parieto-frontal areas, left temporal area, bilateral occipital areas, left thalamus, and lenticular nucleus. The lesions did not show contrast enhancement, and there was no oedema around them. Most lesions displayed restricted diffusion on DWI. Taken together, such radiological features indicated the presence of multiple acute and subacute ischaemic lesions ( Figure 2 ). Doppler carotid ultrasound and echocardiography did not show any abnormalities that could be responsible for formation of thromboembolic material. On brain MRI that was performed on the 16 th day since symptom onset, there was enlargement of the lesions and persistence of restricted diffusion in the lesions in the cerebral cortex and basal ganglia. Moreover, contrast enhancement was observed in multiple, disseminated, well-delineated, oval lesions in the cerebral cortex of both brain hemispheres, pineal gland, and pons; there was no oedema around the lesions. Because a typical evolution of ischaemic lesions in DWI sequences was not observed, contrast enhancement in multiple lesions was observed, and the patient had lung cancer, we diagnosed cerebral metastases ( Figure 3 ).
Discussion
Restricted diffusion on DWI is observed primarily in acute or hyperacute ischaemic infarcts, abscesses, and in certain hypercellular brain tumours. In ischaemic stroke, restriction of diffusion is due to cytotoxic oedema that leads to shrinkage of the extracellular space [1, 9, 10] . A relative restriction of diffusion, that is observed in abscesses, likely results from an increased density of abscess contents that include active and necrotic neutrophils, bacteria, and necrotic tissue, all of which inhibit diffusion of water molecules [1, 7] . Most of demyelinating lesions in multiple sclerosis are characterised by increased ADC values, although certain acute demyelinating lesions can display restriction of diffusion with a corresponding decrease in signal in ADC maps. This finding is explained by a hypothetical presence of cytotoxic oedema in the myelin sheath, which can inhibit diffusion of water molecules in the extracellular space [11] .
Primary brain tumours that display restricted diffusion include lymphomas [3] , medulloblastoma [12] , and highgrade gliomas (especially glioblastoma multiforme) [13] . It is suspected that restriction of diffusion that is observed in primary brain tumours is caused by hypercellular areas (i.e., areas with high cellular indices) [13] [14] [15] [16] in which shrinkage of extracellular space impedes diffusion of water. Other potential causes of restricted diffusion in primary brain tumours include bacterial superinfection [17] and post-radiation tissue necrosis [18] . Also, one should be aware of the T2 shine-through effect that is related to T2-dependent components in DWI maps. Notably, this effect can be verified when DWI are compared with ADC maps, since only true restriction of diffusion causes decreased ADC values [2, 5] .
Restriction of diffusion that is observed in cerebral metastases could result from a high nuclear-cytoplasmic ratio with relative hypercellularity of cancer cells [5] , liquefactive necrosis [7, 18] , and haemorrhage [19] . These factors could impede diffusion of water molecules in the extracellular space, thereby leading to typical findings on DWI and ADC maps [5] .
A potential relationship between primary tumour cell type and presence of cerebral metastases that are characterised by restricted diffusion has been studied by some authors. Duygulu et al., in a study involving 76 patients, did not determine any significant relation between the cell type of primary tumours and presence of cerebral metastases displaying restriction of diffusion. However, those authors noted that cerebral metastases with restricted diffusion were observed primarily in patients with lung cancer (small-cell and non-small-cell carcinoma) or breast cancer. Moreover, 15 patients with colon cancer and prostate cancer also presented with cerebral metastases that displayed restricted diffusion [6] .
In the study by Geijer et al., among 12 patients with cerebral metastases originating from various tumours, one patient with small-cell lung cancer had multiple lesions that suggested lacunar ischaemic infarcts on T2, T1, contrast-enhanced, DWI, and ADC sequences; in that patient, only a large number of lesions that were found throughout the brain indicated an alternative diagnosis. In the same study, half of patients had lung cancer (small-cell, nonsmall-cell, squamous cell carcinoma, and adenocarcinoma), and all cerebral metastases that originated from lung cancer were characterised by restricted diffusion and ring enhancement [8] .
Based on the available literature [5, 7, 8, 18] , characteristic features of cerebral metastases, that are observed on CT and MRI, include distinct contrast enhancement that can be rim-like, tuberous, or homogenous [20] . These features differentiate cerebral metastases from subacute ischaemic infarcts in which contrast enhancement is seen on the borders of ischaemic foci, along the cerebral cortex (so-called luxury perfusion).
The fact that our patient had cerebral metastases that did not display contrast enhancement on initial MRI is exceptional. To the best of our knowledge, this is the first described case of cerebral metastases that were characterised by restricted diffusion and lack of contrast enhancement. Based on previous studies [21] [22] [23] [24] , we suppose that this was due to the fact that the blood-brain barrier was intact during the initial MRI examination, which prevented extravasation of contrast into the metastases. Another potential mechanism could involve a protective role of chemotherapeutics that were initially able to maintain the integrity of the blood-brain barrier [22] . Within two weeks, neoangiogenesis could contribute to disruption of the blood-brain barrier, which in turn could lead to extravasation of contrast material, as observed on the follow-up MRI examination in our patient. This hypothesis can be supported by case reports of patients who were treated with bevacizumab, an inhibitor of angiogenesis. Namely, in these patients, a decrease in or lack of contrast enhancement was observed in cerebral metastases, which was accompanied by reduction of vasogenic oedema [25] . Moreover, discontinuation of bevacizumab led to more pronounced contrast enhancement and oedema [26] . Differential diagnosis in our patient was difficult due to lack of vasogenic oedema that is usually found on T2 and FLAIR images; moreover, vasogenic oedema is characterised by facilitated diffusion on DWI [7] . To date, several cases of metastases that were not accompanied by oedema have been reported [21, 27] , which was explained by preservation of the blood-brain barrier at the early stage of the process of metastasizing.
An overlap between metastatic and ischaemic lesions can further hamper diagnosis. Cerebral metastases can occur in any part of the brain, but they tend to localise preferentially at sites typical for lacunar infarcts, such as the border between white and grey matter, basal ganglia, thalamus, and centrum semiovale [8, 28, 29] . Although most of the cerebral metastases that were observed in our patient were found in the cerebral cortex, which is atypical, similar metastases with a histopathological confirmation have been described in other reports [21, 23] .
It is worth to name other advanced MRI techniques that could improve the differential diagnosis of disseminated lesions that are characterised by restriction of diffusion. Magnetic resonance spectroscopy (MRS) shows an increased Cho/Cr, decreased NAA/Cr, and no change in ml/Cr ratios in the solid part of metastases that are enhancing following contrast administration [4, 24, [30] [31] [32] . Moreover, peaks of lactic acid and lipids can be seen in necrotic metastases [4] . As regards non-enhancing regions of metastases, MRS spectra should be similar to those for the white matter [31, 32] . According to the study by Lin et al., in the centre of acute ischemic brain infarcts, one can observe decreased NAA/Cr and NAA/Cho ratios, as compared to the healthy brain hemisphere; moreover, the peak of lactic acid increases within 12 hours [33] . Due to an overlap of MRS spectra between cerebral metastases and ischaemic infarcts, MRS is not sufficient to differentiate between these diagnoses.
On perfusion-weighted imaging (PWI), cerebral metastases, having a rich vascular supply, display high relative cerebral blood volumes (rCBV), as compared to contralateral white matter [31, [34] [35] [36] . Because hyperacute, acute, and subacute cerebral infracts are characterised by decreased rCBV, PWI can help differentiate between metastases and ischaemic infarcts.
Conclusions
Disseminated and non-contrast enhancing cerebral lesions with restricted diffusion on DWI typically characterise hyperacute and acute ischaemic infarcts, but they can also indicate hypercellular metastases. This latter possibility should be taken into account especially in patients with a history of cancer. If initial MRI in these patients reveals disseminated T2 and FLAIR hyperintensities with no contrast enhancement, follow-up imaging should be performed, as the blood-brain barrier can disrupt due to cancer progression, which can be visualized as contrast enhancement. This approach will help make correct diagnoses. In doubtful cases, PWI and other advanced MRI techniques can be employed.
